Guillain–Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States

Chart-Confirmed Guillain-Barre Syndrome After 2009 H1N1 Influenza Vaccination Among the Medicare Population, 2009-2010

(2013) L. L. Polakowski et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

(2013) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

(2013) Daniel A Salmon et al.   LANCET

Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation

(2013) Gregory D. Zimet et al.   PREVENTIVE MEDICINE

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

(2013) Caitlin N. Dodd et al.   VACCINE

Surveillance for Adverse Events Following Receipt of Pandemic 2009 H1N1 Vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010

(2012) W. K. Yih et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans

(2012) M. E. Wise et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010

(2012) S. K. Greene et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Surveillance for Guillain–Barré Syndrome After Influenza Vaccination Among the Medicare Population, 2009–2010

(2012) Dale R. Burwen et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Safety of influenza vaccines

(2012) John M. Kelso   Current Opinion in Allergy and Clinical Immunology

The clinician’s guide to the anti-vaccinationists’ galaxy

(2012) Gregory A. Poland et al.   HUMAN IMMUNOLOGY

Risk of Guillain-Barré Syndrome Following H1N1 Influenza Vaccination in Quebec

(2012) Philippe De Wals et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Guillain–Barré Syndrome

(2012) Nobuhiro Yuki et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Risk of Guillain-Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009-2010 Seasonal Influenza Vaccines: Results from Self-Controlled Analyses

(2012) Jerome I Tokars et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Influenza vaccine, Guillain–Barré syndrome, and chasing zero

(2012) Gregory A. Poland et al.   VACCINE

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis

(2011) J. Kevin Yin et al.   Influenza and Other Respiratory Viruses

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

(2011) James J. Sejvar et al.   NEUROEPIDEMIOLOGY

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

(2011) Julianne Gee et al.   VACCINE

Guillain-Barré syndrome after exposure to influenza virus

(2010) Helmar C Lehmann et al.   LANCET INFECTIOUS DISEASES

Comment on the contribution by Souayah et al., “Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009”

(2010) Barbara A. Slade et al.   VACCINE

Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009

(2010) Nizar Souayah et al.   VACCINE

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

(2010) James J. Sejvar et al.   VACCINE

Vaccines and Guillain-Barré Syndrome

(2009) Penina Haber et al.   DRUG SAFETY

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

(2009) Barbara A. Slade   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization

(2008) Katrin S. Kohl et al.   VACCINE